CBRE Group Inc
NYSE:CBRE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CBRE Group Inc
NYSE:CBRE
|
US |
|
Flowers Foods Inc
NYSE:FLO
|
US |
|
Liquidia Corp
NASDAQ:LQDA
|
US |
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
IL |
|
Schumag AG
F:SCM
|
DE |
|
Primo Water Corp
TSX:PRMW
|
US |
Wall St Price Targets
CBRE Price Targets Summary
CBRE Group Inc
According to Wall Street analysts, the average 1-year price target for CBRE is 184.846 USD with a low forecast of 171.7 USD and a high forecast of 210 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CBRE's stock price target?
Price Target
184.846
USD
According to Wall Street analysts, the average 1-year price target for CBRE is 184.846 USD with a low forecast of 171.7 USD and a high forecast of 210 USD.
What is the Revenue forecast for CBRE Group Inc?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 5 years is 9%.
What is the Operating Income forecast for CBRE Group Inc?
Projected CAGR
23%
Over the last 14 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 5 years is 23%.
What is the Net Income forecast for CBRE Group Inc?
Projected CAGR
28%
Over the last 14 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 5 years is 28%.
